Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

NGL FINE CHM vs AAREY DRUGS - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    NGL FINE CHM AAREY DRUGS NGL FINE CHM/
AAREY DRUGS
 
P/E (TTM) x 26.8 22.2 120.6% View Chart
P/BV x 4.2 1.2 359.5% View Chart
Dividend Yield % 0.1 0.0 -  

Financials

 NGL FINE CHM   AAREY DRUGS
EQUITY SHARE DATA
    NGL FINE CHM
Mar-24
AAREY DRUGS
Mar-24
NGL FINE CHM/
AAREY DRUGS
5-Yr Chart
Click to enlarge
High Rs2,42568 3,566.3%   
Low Rs1,21125 4,922.8%   
Sales per share (Unadj.) Rs548.0141.0 388.6%  
Earnings per share (Unadj.) Rs66.91.7 4,003.7%  
Cash flow per share (Unadj.) Rs85.72.3 3,766.4%  
Dividends per share (Unadj.) Rs1.750-  
Avg Dividend yield %0.10-  
Book value per share (Unadj.) Rs425.046.5 914.8%  
Shares outstanding (eoy) m6.1828.05 22.0%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x3.30.3 1,010.1%   
Avg P/E ratio x27.227.7 98.0%  
P/CF ratio (eoy) x21.220.4 104.2%  
Price / Book Value ratio x4.31.0 429.0%  
Dividend payout %2.60-   
Avg Mkt Cap Rs m11,2321,299 864.7%   
No. of employees `000NANA-   
Total wages/salary Rs m4515 8,401.5%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m3,3873,956 85.6%  
Other income Rs m14170 202.8%   
Total revenues Rs m3,5284,026 87.6%   
Gross profit Rs m53745 1,207.4%  
Depreciation Rs m11617 685.6%   
Interest Rs m1844 41.4%   
Profit before tax Rs m54453 1,018.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1317 1,987.9%   
Profit after tax Rs m41347 882.1%  
Gross profit margin %15.91.1 1,410.2%  
Effective tax rate %24.112.3 195.1%   
Net profit margin %12.21.2 1,030.4%  
BALANCE SHEET DATA
Current assets Rs m2,1272,826 75.3%   
Current liabilities Rs m8661,665 52.0%   
Net working cap to sales %37.229.3 126.9%  
Current ratio x2.51.7 144.8%  
Inventory Days Days707 985.8%  
Debtors Days Days9661,702 56.7%  
Net fixed assets Rs m1,429207 690.0%   
Share capital Rs m31281 11.0%   
"Free" reserves Rs m2,5951,023 253.8%   
Net worth Rs m2,6261,303 201.5%   
Long term debt Rs m732 23.1%   
Total assets Rs m3,5553,033 117.2%  
Interest coverage x31.12.2 1,398.5%   
Debt to equity ratio x00 11.5%  
Sales to assets ratio x1.01.3 73.0%   
Return on assets %12.13.0 406.1%  
Return on equity %15.73.6 437.7%  
Return on capital %21.37.3 293.3%  
Exports to sales %70.30.4 19,776.9%   
Imports to sales %13.60-   
Exports (fob) Rs m2,38114 16,932.1%   
Imports (cif) Rs m459NA-   
Fx inflow Rs m2,40914 17,132.8%   
Fx outflow Rs m50957 898.9%   
Net fx Rs m1,900-43 -4,465.3%   
CASH FLOW
From Operations Rs m205-30 -683.5%  
From Investments Rs m-268-17 1,575.6%  
From Financial Activity Rs m-1156 -19.4%  
Net Cashflow Rs m-749 -836.1%  

Share Holding

Indian Promoters % 72.7 45.4 160.1%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.0 2.8 0.7%  
FIIs % 0.0 2.8 0.7%  
ADR/GDR % 0.0 0.0 -  
Free float % 27.3 54.6 50.0%  
Shareholders   14,575 16,676 87.4%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare NGL FINE CHM With:   DIVIS LABORATORIES    SUN PHARMA    CIPLA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on NGL FINE CHM vs AAREY DRUGS

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

NGL FINE CHM vs AAREY DRUGS Share Price Performance

Period NGL FINE CHM AAREY DRUGS S&P BSE HEALTHCARE
1-Day -0.63% -2.79% 0.64%
1-Month -10.82% -14.47% -0.82%
1-Year -6.61% 13.40% 42.79%
3-Year CAGR -12.72% 16.84% 20.12%
5-Year CAGR 32.94% 23.51% 26.10%

* Compound Annual Growth Rate

Here are more details on the NGL FINE CHM share price and the AAREY DRUGS share price.

Moving on to shareholding structures...

The promoters of NGL FINE CHM hold a 72.7% stake in the company. In case of AAREY DRUGS the stake stands at 45.4%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of NGL FINE CHM and the shareholding pattern of AAREY DRUGS.

Finally, a word on dividends...

In the most recent financial year, NGL FINE CHM paid a dividend of Rs 1.8 per share. This amounted to a Dividend Payout ratio of 2.6%.

AAREY DRUGS paid Rs 0.0, and its dividend payout ratio stood at 0.0%.

You may visit here to review the dividend history of NGL FINE CHM, and the dividend history of AAREY DRUGS.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Trades Higher | Nifty Above 23,450 | Info Edge & SJVN Jump 5% Sensex Today Trades Higher | Nifty Above 23,450 | Info Edge & SJVN Jump 5%(10:30 am)

Asian markets traded higher on Friday, following the overnight rally on Wall Street, and the release of economic data in the region.